Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis

Varicella zoster virus triggers the immunopathology of giant cell arteritis

(2016) Don Gilden et al.   CURRENT OPINION IN RHEUMATOLOGY

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

(2015) Rebekka Kohlmann et al.   Multiple Sclerosis Journal

Varicella-Zoster Virus Infections in Patients Treated With Fingolimod

(2015) Ann M. Arvin et al.   JAMA Neurology

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

(2015) Rebekka Kohlmann et al.   Multiple Sclerosis Journal

The participation of varicella zoster virus in relapses of multiple sclerosis

(2014) Julio Sotelo et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK

(2014) J. Breuer et al.   NEUROLOGY

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study

(2013) Ali Manouchehrinia et al.   BRAIN

Environmental factors in multiple sclerosis

(2013) Alberto Ascherio   Expert Review of Neurotherapeutics

Initiating oral fingolimod treatment in patients with multiple sclerosis

(2013) Barry A. Singer   Therapeutic Advances in Neurological Disorders

Fingolimod and multiple sclerosis: Four cautionary tales

(2012) D. Bourdette et al.   NEUROLOGY

Increased Risk of Multiple Sclerosis Following Herpes Zoster: A Nationwide, Population-Based Study

(2011) Jiunn-Horng Kang et al.   JOURNAL OF INFECTIOUS DISEASES

The major cause of multiple sclerosis is environmental: genetics has a minor role - No

(2011) Stephen Sawcer   Multiple Sclerosis Journal

Varicella zoster virus in progressive forms of multiple sclerosis

(2010) Graciela Ordoñez et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome

(2009) Johannes Brettschneider et al.   PLoS One

Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay

(2008) P.A.C. Maple et al.   JOURNAL OF CLINICAL VIROLOGY

Humoral and Cellular Immunity to Varicella‐Zoster Virus: An Overview

(2008) Ann M. Arvin   JOURNAL OF INFECTIOUS DISEASES

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET